Experts argue mobile health apps should be reviewed, certified

Article

A viewpoint article recently published in JAMA argued that mobile health (mHealth) apps should be reviewed and certified by experts to “ensure the apps do not post potential harm to their users or have significant security or privacy vulnerabilities.”

A viewpoint article recently published in JAMA argued that mobile health (mHealth) apps should be reviewed and certified by experts to “ensure the apps do not post potential harm to their users or have significant security or privacy vulnerabilities.”

According to the article, there are more than 40,000 medical, health, and fitness apps on the market, and while the U.S. Food and Drug Administration (FDA) has stated that apps acting as medical devices or accessories would require its approval, other health apps-such as ones that retrieve medical content, communicate with practitioners, or log health and fitness activity-would not fall under the agency’s jurisdiction.

Authors Adam C. Powell, PhD; Adam B. Landman, MD; and David W. Bates, MD, state, “Although the FDA has focused on safety, it has largely left the review and certification of apps to the marketplace.” Current reviews of apps are generally personal impressions given by users, “rather than evidence-based, unbiased assessments of clinical performance and data security.” 

Related: Study: 90 percent of health-related Wikipedia articles contain errors

While the authors state that it would be unlikely any organization could review all 40,000 health apps, the top-selling and most clinically-useful apps should be reviewed for safety, accuracy, security, effectiveness, and quality.

“By telegraphing these guidelines, as well as standardized approaches to achieving them, the organization will be able to influence mHealth app developers early in their planning process, enabling them to build their apps with these principles and a review process in mind,” stated the authors.

The article suggested the Office of the National Coordinator for Health Information Technology could help in the development of guidelines and certification of the apps, as it is now doing for electronic health records. 

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Presenters from the Collaborative Care Symposium 2025 give their key takeaways from their presentations.
Erin Tomiyama, OD, PhD, FAAO, offers actionable advice for myopia management and perspective for practitioners ready to refine their approach.
Extended lotilaner 0.25% therapy shows meibomian gland benefits
Mitch Ibach, OD, FAAO, details a presentation he gave with Tanner Ferguson, MD, at the Collaborative Care Symposium 2025.
Carolyn Majcher, OD, FAAO, details a Collaborative Care Symposium 2025 presentation given with Prethy Rao, MD.
Mitch Ibach, OD, FAAO, details the importance of identifying the best candidates and practicing comanagement for refractive surgery.
Lori Wright, JD, sat down to talk about a presentation at Collaborative Care Symposium about the risk under federal statutes and how to minimize that risk as an optometrist or an ophthalmic practice.
Rachelle Lin, OD, MS, FAAO, on collaborating more effectively on neovascular retinal cases
Mark Bullimore, MCOptom, PhD, details the importance of preparing optometric students for myopic patient care in a Collaborative Care Symposium (CCS) 2025 presentation.
Peter Hersh, MD, stated that the key takeaway from a handful of presentations he gave at CCS 2025 is that successfully treating patients with keratoconus is identifying the disease early.
© 2025 MJH Life Sciences

All rights reserved.